A Virtual Prospective Study Exploring Activity Trackers and COVID-19 Infections

Evidation Health

Status: Completed

Conditions: SARS-CoV Infection; Covid19

Study type: Observational

Funder types: Other; Industry; Other U.S. Federal agency

Identifiers

NCT04623138

COVID Signals

Details and patient eligibility

About

Prospective, observational, exploratory study exploring the relationship between passively-collected data from wearable activity devices and SARS-CoV-2 infection

Enrollment: 847 patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Adults 18+ years of age
• Lives in the United States
• Speaks, reads, and understands English
• Willing and able to use and wear a wrist-worn activity device daily, during the day and during sleep, or as much as is possible, for the duration of the study
• Meets minimum software and device requirements for the wrist-worn activity device (Apple iOS 12 and up, Android version 6.0 and up)
• Willing to answer daily, weekly and monthly surveys for the duration of the study
• Willing to provide weekly self-collected saliva samples, plus one additional sample if prompted to do so (up to 9 total samples), and ship back the sample(s) within 24 hours of sample collection

Exclusion criteria

• Self-reported previous diagnosis of COVID-19
• Currently participating in any type of clinical trial
• Lives in the District of Columbia (Washington D.C.), Alaska, Hawaii, Arizona, Nevada, U.S. military base located overseas, or U.S. territories (Puerto Rico, U.S. Virgin Islands, Guam, Northern Mariana Island, or American Samoa)

Trial design

847 participants in 2 patient groups

Garmin Study Device Group

Description:

Individuals who are randomly assigned to receive the Garmin vívosmart® 4

Empatica Study Device Group

Description:

Individuals who are randomly assigned to receive the Empatica E4